Caffeine
"Caffeine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling.
Descriptor ID |
D002110
|
MeSH Number(s) |
D03.132.960.175 D03.438.759.758.824.175
|
Concept/Terms |
Vivarin- Vivarin
- GlaxoSmithKline Brand of Caffeine
Dexitac- Dexitac
- Republic Drug Brand of Caffeine
No Doz- No Doz
- Bristol-Myers Squibb Brand of Caffeine
Quick-Pep- Quick-Pep
- Thompson Brand 2 of Caffeine
|
Below are MeSH descriptors whose meaning is more general than "Caffeine".
Below are MeSH descriptors whose meaning is more specific than "Caffeine".
This graph shows the total number of publications written about "Caffeine" by people in this website by year, and whether "Caffeine" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 | 2003 | 0 | 1 | 1 | 2010 | 3 | 0 | 3 | 2011 | 1 | 0 | 1 | 2012 | 2 | 0 | 2 | 2013 | 0 | 1 | 1 | 2015 | 1 | 0 | 1 | 2016 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Caffeine" by people in Profiles.
-
Alkadhi KA, Alhaider IA. Caffeine and REM sleep deprivation: Effect on basal levels of signaling molecules in area CA1. Mol Cell Neurosci. 2016 Mar; 71:125-31.
-
Alhaider IA, Alkadhi KA. Caffeine treatment prevents rapid eye movement sleep deprivation-induced impairment of late-phase long-term potentiation in the dentate gyrus. Eur J Neurosci. 2015 Nov; 42(10):2843-50.
-
Ghassabian S, Murray M. Simultaneous in vivo phenotyping of CYP enzymes. Methods Mol Biol. 2013; 987:261-7.
-
Alzoubi KH, Abdul-Razzak KK, Khabour OF, Al-Tuweiq GM, Alzubi MA, Alkadhi KA. Caffeine prevents cognitive impairment induced by chronic psychosocial stress and/or high fat-high carbohydrate diet. Behav Brain Res. 2013 Jan 15; 237:7-14.
-
Alzoubi KH, Srivareerat M, Aleisa AM, Alkadhi KA. Chronic caffeine treatment prevents stress-induced LTP impairment: the critical role of phosphorylated CaMKII and BDNF. J Mol Neurosci. 2013 Jan; 49(1):11-20.
-
Alhaider IA, Aleisa AM, Tran TT, Alkadhi KA. Sleep deprivation prevents stimulation-induced increases of levels of P-CREB and BDNF: protection by caffeine. Mol Cell Neurosci. 2011 Apr; 46(4):742-51.
-
Johnson MW, Strain EC, Griffiths RR. Effects of oral caffeine pretreatment on response to intravenous nicotine and cocaine. Exp Clin Psychopharmacol. 2010 Aug; 18(4):305-15.
-
Alhaider IA, Aleisa AM, Tran TT, Alkadhi KA. Caffeine prevents sleep loss-induced deficits in long-term potentiation and related signaling molecules in the dentate gyrus. Eur J Neurosci. 2010 Apr; 31(8):1368-76.
-
Alhaider IA, Aleisa AM, Tran TT, Alzoubi KH, Alkadhi KA. Chronic caffeine treatment prevents sleep deprivation-induced impairment of cognitive function and synaptic plasticity. Sleep. 2010 Apr; 33(4):437-44.
-
Vogalis F, Harvey JR. Altered excitability of intestinal neurons in primary culture caused by acute oxidative stress. J Neurophysiol. 2003 Jun; 89(6):3039-50.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|